1. Home
  2. BXSL vs BLCO Comparison

BXSL vs BLCO Comparison

Compare BXSL & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackstone Secured Lending Fund of Beneficial Interest

BXSL

Blackstone Secured Lending Fund of Beneficial Interest

HOLD

Current Price

$26.92

Market Cap

6.4B

Sector

Finance

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$16.98

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BXSL
BLCO
Founded
2018
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Ophthalmic Goods
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
6.0B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
BXSL
BLCO
Price
$26.92
$16.98
Analyst Decision
Buy
Hold
Analyst Count
8
14
Target Price
$29.38
$17.31
AVG Volume (30 Days)
1.8M
347.4K
Earning Date
11-10-2025
10-29-2025
Dividend Yield
11.36%
N/A
EPS Growth
N/A
N/A
EPS
2.66
N/A
Revenue
$1,413,784,000.00
$4,976,000,000.00
Revenue This Year
$9.05
$8.08
Revenue Next Year
$0.28
$5.77
P/E Ratio
$10.20
N/A
Revenue Growth
10.58
6.23
52 Week Low
$24.85
$10.45
52 Week High
$34.64
$18.55

Technical Indicators

Market Signals
Indicator
BXSL
BLCO
Relative Strength Index (RSI) 39.51 58.77
Support Level $28.03 $16.74
Resistance Level $28.59 $17.18
Average True Range (ATR) 0.40 0.37
MACD -0.17 -0.03
Stochastic Oscillator 1.23 54.19

Price Performance

Historical Comparison
BXSL
BLCO

About BXSL Blackstone Secured Lending Fund of Beneficial Interest

Blackstone Secured Lending Fund is a non-diversified, closed-end management investment company. The investment objectives of the company are to generate current income and, to a lesser extent, long-term capital appreciation. The company seeks to achieve its investment objectives by investing in originated loans and other securities, including syndicated loans of private U.S. companies, typically in the form of first lien senior secured and unitranche loans, unsecured and subordinated loans, and other securities.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: